Azithromycin
| ingoa hua | AZITHROMIKININA | ||
| CAS | 83905-01-5 | ||
| Waehere HS | 29419090 | ||
| Whakamutunga | 5tau | ||
| Paerewa | EP o nāianei | ||
| Te ahua | Te paura tioata ma, tata ma ranei | ||
| Wairewa | Kare e rewa ki te wai, ka memeha noa ki te waiwaro anhydrous me te inmethylene chloride | ||
| TautuhingaIR | E rite ana ki a Azithromycin RSS me maama me te kore tae .I waenga i te 9.0 me te l1.0I waenga i te -45 me te -49 | ||
| Matū whai pānga | poke L | ≤0.5% | |
| Te poke M | ≤0.5% | ||
| Te poke E | ≤0.5% | ||
| Te poke F | ≤0.5% | ||
| Te poke D me J | ≤0.5% | ||
| Te poke I | ≤0.5% | ||
| Te poke C | ≤0.5% | ||
| Te poke N | ≤0.5% | ||
| Te poke H | ≤0.5% | ||
| Te poke A | ≤0.5% | ||
| Te poke P | ≤0.5% | ||
| pokeO | ≤0.5% | ||
| Te poke G | ≤0.2% | ||
| Te poke B | ≤2.0% | ||
| Tetahi atu poke | ≤0.2% | ||
| Nga poke katoa | ≤3.0% | ||
| Te whakarewa taumahas | ≤25ppm | ||
| Wai | 1.8%-6.8% | ||
| Te pungarehu ngongo | ≤0.2% | ||
| Whakamātautau I runga i te kaupapa anhydrous | 98.3% | ||
| Te toenga whakarewa | Acetone | ≤3200ppm | |
| Mewaro | ≤3000ppm | ||
| Dichloromethane | ≤600ppm | ||
| Kiato rahi | 0.35~0.65g/ml | ||
| Kiato paopao | 0.65~0.85g/ml | ||
| Te tohatoha rahi matūriki | ≥80% 40mesh | ||
| mahi | He kaha te ngakau me nga hua neuroprotective a Carvedilol: kaore i rite ki nga antagonists β-receptor noa, ko te whakamahi mo te wa roa o tenei hua i roto i nga turoro hypertensive e kore e taea anake te whakanui i nga oko coronary me nga whatukuhu, te whakaiti i te aukati vascular peripheral, engari ka whakaiti hoki i te tohanga punaha. Me te parenga tohanga puohu, he pai te whakahaere i te toto toto tiketike. Ko tenei hua he whakamarumaru mo te mahi renal, kaore e whakarereke i te rere o te toto renal, engari ka whakaiti i te microalbuminuria, ka whakaheke i te aukati vascular renal, me te pai o te mana whakahaere ki nga lipids toto. | ||
Tuhia to korero ki konei ka tukuna mai ki a matou
